{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:43:44Z","timestamp":1784324624965,"version":"3.55.0"},"reference-count":54,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AT001495\u201001A1"],"award-info":[{"award-number":["1R01AT001495\u201001A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["2R01 AT001495\u201005A1"],"award-info":[{"award-number":["2R01 AT001495\u201005A1"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001419","name":"Food Allergy Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Concurrent sensitization to peanut (<jats:styled-content style=\"fixed-case\">PN<\/jats:styled-content>) and tree nuts (<jats:styled-content style=\"fixed-case\">TN<\/jats:styled-content>), the most dangerous food allergies, is common. Current oral immunotherapy (<jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content>) is not fully satisfactory.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine whether the herbal formula B\u2010<jats:styled-content style=\"fixed-case\">FAHF<\/jats:styled-content>\u20102 (<jats:styled-content style=\"fixed-case\">BF<\/jats:styled-content>2) ameliorates <jats:styled-content style=\"fixed-case\">PN<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">TN OIT<\/jats:styled-content> adverse reactions and enhances persistence of a tolerant state.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Concurrently sensitized PN\u2010, walnut\u2010 (<jats:styled-content style=\"fixed-case\">WN<\/jats:styled-content>) and cashew (<jats:styled-content style=\"fixed-case\">CSH<\/jats:styled-content>)\u2010allergic mice received 1\u2010day <jats:styled-content style=\"fixed-case\">PN<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">WN<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">CSH<\/jats:styled-content> rush <jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content> plus 3\u00a0weeks of maintenance dosing, with or without 3\u00a0weeks prior and 3\u00a0weeks <jats:styled-content style=\"fixed-case\">BF<\/jats:styled-content>2 co\u2010treatment. Anaphylactic symptom scores, core body temperatures, plasma histamine levels, basophil numbers, antigen\u2010specific IgE, cytokine levels, and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20104, <jats:styled-content style=\"fixed-case\">INF<\/jats:styled-content>\u2010\u03b3 and Foxp3 gene promoter <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> methylation status, and their correlation with final challenge symptom scores were determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">BF<\/jats:styled-content>2+<jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content>\u2010treated mice experienced significantly fewer and less severe adverse reactions than <jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content>\u2010only\u2010treated mice (<jats:italic>P<\/jats:italic>&lt;.01) during the 1\u2010day rush <jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content> build\u2010up dose phase. Both <jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content>\u2010only and <jats:styled-content style=\"fixed-case\">BF<\/jats:styled-content>2+<jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content> mice showed significant desensitization (<jats:italic>P<\/jats:italic>&lt;.01 and .001, respectively) at 1\u00a0week post\u2010therapy challenge, being greater in <jats:styled-content style=\"fixed-case\">BF<\/jats:styled-content>2+<jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content> mice. All sham\u2010treated and 91% of <jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content>\u2010treated mice experienced anaphylaxis whereas only 21% of <jats:styled-content style=\"fixed-case\">BF<\/jats:styled-content>2+<jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content>\u2010treated mice exhibited reactions during 5\u20106\u00a0weeks of dose escalation single <jats:styled-content style=\"fixed-case\">PN<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">TN<\/jats:styled-content> challenges. Greater and more persistent protection in <jats:styled-content style=\"fixed-case\">BF<\/jats:styled-content>2+<jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content> mice was associated with significantly lower plasma histamine and IgE levels, increased <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b3\/<jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20104 and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201010\/<jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20104 ratios, <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> remethylation at the <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20104 promoter and demethylation at <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b3 and Foxp3 promoters. Final challenge symptom scores were inversely correlated with <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20104 <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> methylation levels (<jats:italic>P<\/jats:italic>&lt;.0002) and positively correlated with <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b3 and Foxp3 gene promoter methylation levels (<jats:italic>P<\/jats:italic>&lt;.0011) (<jats:italic>P<\/jats:italic>&lt;.0165).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Clinical Relevance<\/jats:title><jats:p>Combined <jats:styled-content style=\"fixed-case\">BF<\/jats:styled-content>2\/<jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content> therapy was safer and produced longer post\u2010treatment protection and more tolerance\u2010prone immunological and epigenetic modifications than <jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content> alone. <jats:styled-content style=\"fixed-case\">BF<\/jats:styled-content>2\/<jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content> may provide an additional <jats:styled-content style=\"fixed-case\">OIT<\/jats:styled-content> option for patients with concurrent PN\/TN and other food allergies.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cea.12936","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T08:42:37Z","timestamp":1491900157000},"page":"1038-1049","source":"Crossref","is-referenced-by-count":31,"title":["B\u2010<scp>FAHF<\/scp>\u20102 plus oral immunotherapy (<scp>OIT<\/scp>) is safer and more effective than <scp>OIT<\/scp> alone in a murine model of concurrent peanut\/tree nut allergy"],"prefix":"10.1111","volume":"47","author":[{"given":"K. D.","family":"Srivastava","sequence":"first","affiliation":[{"name":"Department of Pediatrics Jaffe Food Allergy Institute Center for Integrative Medicine for Immunology and Wellness Icahn School of Medicine at Mount Sinai New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Jaffe Food Allergy Institute Center for Integrative Medicine for Immunology and Wellness Icahn School of Medicine at Mount Sinai New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Jaffe Food Allergy Institute Center for Integrative Medicine for Immunology and Wellness Icahn School of Medicine at Mount Sinai New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Jaffe Food Allergy Institute Center for Integrative Medicine for Immunology and Wellness Icahn School of Medicine at Mount Sinai New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. E.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Jaffe Food Allergy Institute Center for Integrative Medicine for Immunology and Wellness Icahn School of Medicine at Mount Sinai New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nowak\u2010W\u0119grzyn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Jaffe Food Allergy Institute Center for Integrative Medicine for Immunology and Wellness Icahn School of Medicine at Mount Sinai New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. A.","family":"Sampson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Jaffe Food Allergy Institute Center for Integrative Medicine for Immunology and Wellness Icahn School of Medicine at Mount Sinai New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-2427","authenticated-orcid":false,"given":"X.\u2010M.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Jaffe Food Allergy Institute Center for Integrative Medicine for Immunology and Wellness Icahn School of Medicine at Mount Sinai New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-0204"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.08.016"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.02.001"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12437"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.10.008"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12598"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-016-0616-7"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.11.020"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.02.038"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2008.03016.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.02.030"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2014.29"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200316142"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-010-9487-1"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.10.023"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.05.012"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.06.025"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.09.042"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.11.042"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2010.10.010"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.11.010"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.12.1037"},{"key":"e_1_2_7_24_1","first-page":"117","article-title":"Improving the safety of oral immunotherapy for food allergy","author":"Vazquez\u2010Ortiz M","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12567"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-10-7"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.04.009"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.11.034"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.11.011"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.04.009"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.3177\/jnsv.61.400"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.12.1107"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2010.05.005"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.06.015"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.04.029"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2010.03643.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2014.07.021"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.09.013"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2015.05.018"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000439"},{"key":"e_1_2_7_41_1","volume-title":"NRCGuide for the Care and Use of Laboratory Animals","author":"Institute of Laboratory Animal Resources Commission of Life Sciences","year":"1996"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2012.03.008"},{"key":"e_1_2_7_43_1","unstructured":"Administration FAD.International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidance for industry Q3C Impurities:Residual Solvents. In:Administration USFaDed. 2012."},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.08.034"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1193787"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfm290"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-10-1"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2012.33.3607"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.05.022"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12243"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2487"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838105"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141116"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.03.057"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.004"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcea.12936","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cea.12936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T08:01:24Z","timestamp":1696233684000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cea.12936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1111\/cea.12936"],"URL":"https:\/\/doi.org\/10.1111\/cea.12936","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]}}}